Synthetic Biologics Inc Stock Nyse
Equities
US87164U1025
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.68M |
---|---|---|---|---|---|
Net income 2024 * | -28M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.55
x | P/E ratio 2025 * |
-0.59
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.12% |
Latest transcript on Synthetic Biologics Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 15-05-31 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 12-02-29 |
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 05-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 20-11-10 |
Jeffrey Kraws
CHM | Chairman | 59 | 05-12-31 |
1st Jan change | Capi. | |
---|---|---|
-3.77% | 102B | |
+1.72% | 96.07B | |
-1.80% | 21.66B | |
-17.45% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.05% | 13.79B | |
-1.03% | 13.33B | |
+18.92% | 10.94B |